Dendritic cell-based immunotherapy for myeloid leukemias. - Wikidata - wikimedia - TriplyDB

Dendritic cell-based immunotherapy for myeloid leukemias.

Dendritic cell-based immunotherapy for myeloid leukemias.

http://www.wikidata.org/entity/Q37420778

about

Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)The role of tumor/dendritic cell interactions in the regulation of anti-tumor immunity: the good, the bad, and the ugly Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancer Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma Regulation of hematopoietic and leukemic stem cells by the immune system.Spontaneous remission of acute myeloid leukemia.Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes.BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.Chronic Myelocytic Leukemia (CML) Patient-Derived Dendritic Cells Transfected with Autologous Total RNA Induces CML-Specific Cytotoxicity.Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.

P2860

Q26770391-0B20BF67-03DD-40E0-8320-08E8EB24EE21 Q30413213-83CE8311-A5B3-4ACA-8FA1-D8C27FD6F4B5 Q33820274-30747450-07E7-4332-B887-18DCDAC4FBEB Q36740905-144AC3FD-43A9-4AF8-A20F-190703CC282E Q37565482-DA950AA4-C90A-4664-88A1-5DAA3A8F08B6 Q38225994-C2986BA6-DD95-4CE7-B2F8-3D2FDBD4F5F3 Q38256921-5CBB483B-75CD-4BAF-BC9C-B9A5561055EB Q38943954-AE2B9842-E354-4DA7-BED5-C8A5C818BAA1 Q44460438-9B0E9FD5-E074-4FBD-A981-CE98912729B7 Q47146006-5C95A39C-FDDB-44F6-91B5-2FFFDE0BE892 Q52716912-48B51205-CF27-42A0-AA91-0B3BB71EC66C Q55354182-99BF74AD-CBFF-4403-87B7-C6D5991B205E

P2860

Dendritic cell-based immunotherapy for myeloid leukemias.

http://www.wikidata.org/entity/Q37420778

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dendritic cell-based immunotherapy for myeloid leukemias.

@en

Dendritic cell-based immunotherapy for myeloid leukemias.

@nl

type

label

Dendritic cell-based immunotherapy for myeloid leukemias.

@en

Dendritic cell-based immunotherapy for myeloid leukemias.

@nl

prefLabel

Dendritic cell-based immunotherapy for myeloid leukemias.

@en

Dendritic cell-based immunotherapy for myeloid leukemias.

@nl

P1433

Q37420778-BE3434E7-140B-45DF-8C46-7D1404490983

P1476

Q37420778-A7CFD3A4-0255-46E1-8218-D2BCA68B5F96

P2093

Q37420778-275730C2-D572-4BAF-B9AC-294A3C44FE4B

P2860

Q37420778-013E6226-B54A-4D21-BF24-4C1C07A77107

Q37420778-0369B9EF-3679-4EEB-A2F4-1FF99061C727

Q37420778-053AFB93-FD83-4D7D-B617-50441F81F9D5

Q37420778-0B19BC14-6821-4998-9069-D7A9F727BA01

Q37420778-0B621C42-3F4E-4EC8-A3C3-A5781920FF7F

Q37420778-0BDF6DB9-421B-4975-A158-1DC600AA9758

Q37420778-0D6B5BCD-FC3A-4FAF-BF06-BAA1AC56110F

Q37420778-0FBA9FEE-9D97-4E14-9263-ACE98E6B6012

Q37420778-10E18511-2648-42D3-B798-711465EE048B

Q37420778-1616CAAE-E65D-4CD5-83A6-D0C8E8AFC900

P304

Q37420778-5D2BA8B9-65F7-4C5D-81AC-F27B14A73973

P31

Q37420778-E1451790-C006-4586-BA12-DAC2E3E04F39

P356

Q37420778-7B5C26BE-5F8C-4104-A00F-AAAB3442D633

P478

Q37420778-2D0EE65F-FEB8-47FA-8388-C08DF9138200

P50

Q37420778-31A8BFC3-CD99-4F68-B5B7-B039C3CE291B

Q37420778-C3FD85AB-6CD9-4601-A636-3C4B50028B83

Q37420778-EAFB4811-6A5E-43CF-ABE0-6DB6DCD8E0D2

P577

Q37420778-8EC63973-FAC7-4CA7-B90F-143B1B311369

P5875

Q37420778-31684D87-CE39-4EDD-9016-C554EF877A7B

P698

Q37420778-B44E1B38-A0BE-4CC5-A0A8-E7EB396FEE00

P921

Q37420778-A98649C9-27DC-43E5-B106-FFC5C583D201

P932

Q37420778-4624434C-8262-47A0-94FE-41F6E3123BB6

P356

FIMMU.2013.00496

P1433

Frontiers in Immunology

P1476

Dendritic cell-based immunotherapy for myeloid leukemias

@en

P2093

Adrian F Ochsenbein

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials

Nivolumab plus ipilimumab in advanced melanoma.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Cancer statistics, 2013

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

P304

496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2013.00496

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Carsten Riether

Christian Schürch

Adrian F Ochsenbein

P577

2013-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259743180

http://www.w3.org/2001/XMLSchema#string

P698

24427158

http://www.w3.org/2001/XMLSchema#string

P921

P932

3876024

http://www.w3.org/2001/XMLSchema#string